Nitrasanata Dharma Tbk (JECX.JK) stock: key figures, P/E, revenue and dividend

Health Care · Indonesia

Price
1,035.00 IDR
Market cap
3.37 tn IDR
P/E (2025)
–
P/S (2025)
3.63
Dividend yield
0.00 %
Net margin
7.82 %
Return on equity (ROE)
–
Return on assets (ROA)
–

Nitrasanata Dharma Tbk financials

Fiscal year20242025
Revenue887.72 bn IDR926.76 bn IDR
Gross profit554.54 bn IDR576.69 bn IDR
Operating income111.41 bn IDR125.63 bn IDR
EBIT116.65 bn IDR129.20 bn IDR
Net income62.47 bn IDR72.50 bn IDR

Full history since 2023, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About Nitrasanata Dharma Tbk

PT Nitrasanata Dharma operates as a provider of eye health services in Indonesia. The company provides ophthalmic services including cataract, lens and refractive surgery, glaucoma treatment, retina care, okuloplasty and orbital reconstruction, pediatric ophthalmology and strabismus management, contact lens services, infection and immunology care, neuro-ophthalmology, dry eye treatment, and ophthalmic trauma services. In addition, it offers solutions, such as eye check diagnostics, tele-ophthalmology consultations, and services through the thyroid eye center. PT Nitrasanata Dharma was founded in 1984 and is headquartered in Jakarta Pusat, Indonesia.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 30.10.2026. Details in the risk notice.